QuinStreet (QNST) director gets 9,938 RSUs; holds 123,078 shares
QuinStreet (QNST) director Matthew Glickman reported an equity grant on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
QuinStreet (QNST) director Matthew Glickman reported an equity grant on a Form 4. On October 30, 2025, he acquired 9,938 shares of common stock pursuant to a Restricted Stock Unit (RSU) award at a stated price of $0.0 under transaction code A. The RSUs begin vesting on October 30, 2025 and vest daily over one year.
After the transaction, Glickman beneficially owns 123,078 shares directly and 10,000 shares indirectly through a trust.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 9,938 | $0.00 | $0.00 |
| Holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Represents shares of common stock that are issuable pursuant to a Restricted Stock Unit (RSU) award. The vesting commencement date of the RSU award is October 30, 2025 and it vests daily over one year.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did QuinStreet (QNST) disclose on this Form 4?
How many RSUs were granted to the QNST director and at what price?
What is the vesting schedule for the QNST director’s RSUs?
What are Matthew Glickman’s holdings after the reported transaction?
What transaction code is listed on the Form 4 for QNST?
What is the issuer name and ticker in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.